Chairman of Plexus Corp. Sells Over $1 Million in Company Stock
PLXS sits 90% above its 52-week low of $103.43 on elevated volume (2.9× avg).
Summary
Dean A. Foate, Chairman of the Board at Plexus Corp., sold over $1 million worth of common stock, contributing to a pattern of recent insider selling.
Key Events · Ownership and Investor Activity · PLXS
-
Chairman Sells Shares
Dean A. Foate, Chairman of the Board, sold 5,000 shares of common stock for approximately $1.02 million on February 2, 2026.
-
Follows Intent to Sell
This sale follows a Form 144 filed by Mr. Foate on the same day, indicating his intent to dispose of shares.
-
Part of Broader Insider Selling
This transaction contributes to a recent pattern of insider selling at Plexus Corp., including significant sales by the CEO and CFO this week.
Analysis · PLXS · Manufacturing
This Form 4 filing reports that Dean A. Foate, Chairman of the Board at Plexus Corp., sold 5,000 shares of common stock for approximately $1.02 million. This transaction follows a Form 144 filing by Mr. Foate on the same day, indicating his intent to sell shares. The sale, while a small percentage of the company's market capitalization, is significant in absolute dollar terms and occurs amidst a cluster of insider selling activity this week, including a $1.67 million sale by the CEO and another Form 144 filing by the CFO. This pattern of executive and director sales could signal a lack of confidence or a desire for liquidity among key insiders.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLXS was trading at $196.28 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $103.43 to $208.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.